These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3103098)

  • 1. Chromatin association and DNA binding properties of the c-fos proto-oncogene product.
    Renz M; Verrier B; Kurz C; Müller R
    Nucleic Acids Res; 1987 Jan; 15(1):277-92. PubMed ID: 3103098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of modification in c-fos and its associated protein p39: modulation of DNA binding by phosphorylation.
    Müller R; Bravo R; Müller D; Kurz C; Renz M
    Oncogene Res; 1987; 2(1):19-32. PubMed ID: 3146046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fos-associated protein p39 is the product of the jun proto-oncogene.
    Rauscher FJ; Cohen DR; Curran T; Bos TJ; Vogt PK; Bohmann D; Tjian R; Franza BR
    Science; 1988 May; 240(4855):1010-6. PubMed ID: 3130660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular distribution of the c-fos antigen during the cell cycle.
    Rahm M; Hultgårdh-Nilsson A; Jiang WQ; Sejersen T; Ringertz NR
    J Cell Physiol; 1990 Jun; 143(3):475-82. PubMed ID: 1694182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-ets-1 protein is chromatin associated and binds to DNA in vitro.
    Pognonec P; Boulukos KE; Ghysdael J
    Oncogene; 1989 Jun; 4(6):691-7. PubMed ID: 2660071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of proto-oncogenes and salivary gland cell proliferation.
    Kousvelari E; Yeh CK; Mertz PM; Chinchetru M
    Adv Dent Res; 1990 Jun; 4():61-8. PubMed ID: 2169754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-type specific multiprotein complex formation over the c-fos serum response element in vivo: ternary complex formation is not required for the induction of c-fos.
    König H
    Nucleic Acids Res; 1991 Jul; 19(13):3607-11. PubMed ID: 1906604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapidly inducible DNA-binding activity which binds upstream of the c-fos proto-oncogene.
    Hayes TE; Kitchen AM; Cochran BH
    J Cell Physiol Suppl; 1987; Suppl 5():63-8. PubMed ID: 3119603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denervation of mouse skeletal muscle differentially affects the expression of the jun and fos proto-oncogenes.
    Bessereau JL; Fontaine B; Changeux JP
    New Biol; 1990 Apr; 2(4):375-83. PubMed ID: 2126956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-dominant negative mutants of Fos and Jun.
    Ransone LJ; Visvader J; Wamsley P; Verma IM
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3806-10. PubMed ID: 2111017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-binding activity of Jun is increased through its interaction with Fos.
    Allegretto EA; Smeal T; Angel P; Spiegelman BM; Karin M
    J Cell Biochem; 1990 Apr; 42(4):193-206. PubMed ID: 2111328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
    Mountz JD; Steinberg AD
    J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
    Owen TA; Bortell R; Yocum SA; Smock SL; Zhang M; Abate C; Shalhoub V; Aronin N; Wright KL; van Wijnen AJ
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9990-4. PubMed ID: 2124710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear proto-oncogenes fos and jun.
    Ransone LJ; Verma IM
    Annu Rev Cell Biol; 1990; 6():539-57. PubMed ID: 2125830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of the TCF phosphorylation state and the chromatin structure in the negative transcription regulation of the c-fos proto-oncogene in E1A + c-Ha-ras transformed cells].
    Abramova MV; Kukushkin AN; Pospelova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 2002; 36(1):66-75. PubMed ID: 11862715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.